SCHEMBL7871705

SCHEMBL7871705

Cc1nc2cccc3nc(SCCCCCN)c1n23

nearest known ligand 0.33

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
AURKA O14965 1/20 0.33
HTT P42858 1/20 0.32
HASPIN Q8TF76 1/20 0.30
MAPT P10636 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7868701 0.99 HTT (0.33) AURKAHTTHASPIN
SCHEMBL7863487 0.78 HSD17B10 (0.49) MAPT
SCHEMBL7868808 0.77 HSD17B10 (0.50) MAPT
SCHEMBL7868927 0.68 HTT (0.38) HTTHASPIN
SCHEMBL7863472 0.68 HTT (0.38) HTTHASPIN
SCHEMBL7863446 0.66 HTT (0.39) HTTHASPIN
SCHEMBL9001971 0.59 CDK8 (0.40)
SCHEMBL8915226 0.59 HSD17B10 (0.61)
SCHEMBL11152425 0.58 ALDH1A1 (0.58)
SCHEMBL8914849 0.58 ALDH1A1 (0.58)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010051631-A1 Tricyclic compounds, their production and use TAKATANI MUNEO (JP) 2001-12-13 US disclosed
US-6251905-B1 Tricyclic compounds, their production and use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2001-06-26 US disclosed
EP-0771319-A1 TRICYCLIC COMPOUNDS, THEIR PRODUCTION AND USE Takeda Chemical Industries, Ltd. (JP) 1997-05-07 EP disclosed
WO-1996002542-A1 TRICYCLIC COMPOUNDS, THEIR PRODUCTION AND USE TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1996-02-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010051631-A1 Tricyclic compounds, their production and use PDGFA, HGF, REN AURKA 2991/4885HTT 710/4885HASPIN 3077/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.